title: Eosinophilic ascites: taxol-induced hypersensitivity?
authors.forename: T K
authors.initials: TK
authors.lastname: Kobayashi
authors.forename: M
authors.initials: M
authors.lastname: Muramatsu
authors.forename: M
authors.initials: M
authors.lastname: Ueda
authors.forename: T
authors.initials: T
authors.lastname: Nishino
authors.forename: M
authors.initials: M
authors.lastname: Bamba
authors.forename: M
authors.initials: M
authors.lastname: Urabe
authors.forename: S
authors.initials: S
authors.lastname: Moritani
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D001201:Ascites / Q000209:etiology*; D004342:Drug Hypersensitivity; D004802:Eosinophilia / Q000209:etiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology; D017239:Paclitaxel / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel